SALK and Paracelsus Medical University in Salzburg, Austria, has implemented Elekta's Agility 160-leaf multileaf collimator (MLC) for use in radiotherapy treatments.
The new solution is designed to provide clinicians with precise dose sculpting capabilities and lower non-therapeutic radiation dose delivered to the patient.
SALK and Paracelsus Medical University radiotherapy and radio-oncology department chairman and professor Felix Sedlmayer said looking at several prostate cancer cases, the medical centre has calculated a measurable improvement in dose shaping precision with Agility's high-resolution, five millimetre leaves.
"This greater precision improves our ability to focus radiation to the tumour, while strictly limiting exposure to surrounding critical structures such as the rectum and bladder," Sedlmayer added.
"We were astonished at the amount of healthy tissue dose reduction we could achieve. This capacity theoretically enables us to improve outcomes and reduce the potential for complications."
The solution, which is in its first month of use, now helps the hospital treat 50 patients a day.